| 1 |
Hanssen LE, Hanssen KF, Myren J. Inhibition of secretin release and pancreatic bicarbonate secretion after duodenal acidification by somatostatin infusion in man. Scand J Gastroenterol 1976; 11 Suppl 41: 15. |
| 2 |
Hanssen LE, Torjesen P. Radioimmunoassay of secretin in human plasma. Scand J Gastroenterol 1976; 11 Suppl 38: 3. |
| 3 |
Osnes M, Hanssen LE, Myren J. Pancreatic secretion obtained during endoscopic cannulation of the main pancreatic duct after intraduodenal acidification in man. Scand J Gastroenterol 1976; 11 Suppl 38: 5. |
| 4 |
Osnes M, Hanssen LE, Myren J. An endoscopic method for the study of the exocrine pancreatic secretion in man. Endoscopy 1976; 8: 124-6. |
| 5 |
Osnes M, Hanssen LE, Myren J. Study of pancreatic secretion during endoscopic retrograde cannulation. Scand J Gastroenterol 1976; 11 Suppl 41: 28. |
| 6 |
Hanssen LE. The effect of atropine on secretin release and pancreatic bicarbonate secretion after duodenal acidification in man. Acta Endocrinol (Coph) 1977; 85 Suppl 212: 195. |
| 7 |
Hanssen LE, Hanssen KF, Myren J. Immunoreactive secretin is released into the duodenal juice in man. Acta Hepato-Gastroenterol (Stuttg) 1977; 24: 493. |
| 8 |
Hanssen LE, Hanssen KF, Myren J. Inhibition of secretin release and pancreatic bicarbonate secretion by somatostatin infusion in man. Scand J Gastroenterol 1977; 12: 391-4. |
| 9 |
Hanssen LE, Kåresen R, Aune S. Plasma immunoreactive secretin response to acidification in pancreatectomized patients. Irish J Med 1977; 146 Suppl 1: 31. |
| 10 |
Hanssen LE, Torjesen P. Radioimmunoassay of secretin in human plasma. Scand J Gastroenterol 1977; 12: 481-8. |
| 11 |
Osnes M, Hanssen LE, Flaten O, Myren J. The exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man. Irish J Med 1977; 146 Suppl 1: 8. |
| 12 |
Osnes M, Hanssen LE, Flaten O, Myren J. The exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man. Scand J Gastroenterol 1977; 12 Suppl 45: 67. |
| 13 |
Osnes M, Hanssen LE, Myren J. Untersuchungen der Pankreassekretion mittels eines neuen endoskopischen Modells. In: Lindner H, editor. Fortschritte der Gastroenterologischen Endoskopie. Band 8. Baden-Baden, Brüssel: Gerhard Witzstrock, 1977: 186-8. |
| 14 |
Hanssen LE. The effect of atropine on secretin release and pancreatic bicarbonate secretion after duodenal acidification in man. Advanc Exp Med Biol 1978; 106: 217-20. |
| 15 |
Hanssen LE, Hanssen KF, Myren J. Immunoreactive secretin is released duodenal juice in man. Scand J Gastroenterol 1978; 13 Suppl 49: 79. |
| 16 |
Hanssen LE, Osnes M, Flaten O, Myren J. Immunoreactive secretin release and pure pancreatic juice after duodenal infusion of bile in man. Advanc Exp Med Biol 1978; 106: 221-5. |
| 17 |
Hanssen LE, Osnes M, Flaten O, Myren J. Response of plasma secretin and pure pancreatic juice to intraduodenal bile infusions in man. Scand J Gastroenterol 1978; 13 Suppl 49: 80. |
| 18 |
Hanssen LE, Osnes M, Myren J. Pancreatic secretion obtained by endoscopic cannulation of the main pancreatic duct and secretin release after duodenal acidification in man. Scand J Gastroenterol 1978; 13: 325-30. |
| 19 |
Myren J, Schrumpf E. Hanssen LE, Vatn MH, editors. The 2nd International symposium on gastrointestinal hormones. Scand J Gastroenterol 1978; 13 Suppl 49. |
| 20 |
Osnes M, Hanssen LE, Flaten O, Myren J. Exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man. Gut 1978; 19: 180-4. |
| 21 |
Aune S, Hanssen LE, Kåresen R. The effect of peroral glucose and insulin hypoglycemia on plasma immunoreactive secretin (IRS) after total pancreatectomy. Eur Surg Res 1979; 11 Suppl 2: 5-6. |
| 22 |
Flaten O, Osnes M, Hanssen LE, Myren J. Activation of zymogens in pure pancreatic juice (PPJ) by enteropeptidase. Gastroenterol Clin Biol 1979; 3: 303-4. |
| 23 |
Hanssen LE. Pure bile salts release secretin (IRS) at pH 6.5 in man. Dan Med Bull 1979; 26 Suppl 1: 18. |
| 24 |
Hanssen LE, Kåresen R, Aune S. Immunoreactive secretin release in patients after duodenectomy and partial or total pancreatectomy. Scand J Gastroenterol 1979; 14: 997-1000. |
| 25 |
Hanssen LE, Kåresen R, Aune S. Secretin release by peroral glucose in duodenectomized and pancreatectomized patients. Dan Med Bull 1979; 26 Suppl 1: 24. |
| 26 |
Hotz J, Hartmann W, Nehls W, Goebell H, Hanssen LE. Release of secretin and stimulation of pancreatic and bile secretion by duodenal taurocholate perfusion compared to effects of duodenal HCl in cats. Gastroenterology 1979; 76: 1156. |
| 27 |
Hotz J, Hartmann W, Nehls W, Goebell H, Hanssen LE. Stimulation of pancreatic secretion and bile flow, and release of secretin during duodenal perfusion of taurocholate and HCl in cats. Gastroenterol Clin Biol 1979; 3: 304-5. |
| 28 |
Osnes M, Hanssen LE, Flaten O, Larsen S, Myren J. The effect of pure pancreatic juice on bile-induced exocrine pancreatic secretion and immunoreactive secretin release in man. Gastroenterol Clin Biol 1979; 3: 305-6. |
| 29 |
Osnes M, Hanssen LE, Larsen S. The unstimulated pancreatic secretion obtained by endoscopic cannulation, and the plasma secretin levels in man. Scand J Gastroenterol 1979; 14: 503-12. |
| 30 |
Osnes M, Hanssen LE, Larsen S. The unstimulated pancreatic secretion and immunoreactive secretin release after endoscopic cannulation of the main pancreatic duct in man. Gastroenterol Clin Biol 1979; 3: 305. |
| 31 |
Flaten O, Hanssen LE, Osnes M, Myren J. The GIP-release after bile is not caused by bile salts. Scand J Gastroenterol 1980; 15: 910. |
| 32 |
Hanssen LE. The effect of pure synthetic bile salts on secretin release. Hepato-Gastroenterology (Stuttg) 1980; 27: 79. |
| 33 |
Hanssen LE. Pure synthetic bile salts release immunoreactive secretin in man. Scand J Gastroenterol 1980; 15: 461-3. |
| 34 |
Hanssen LE. Studies on the regulation of the plasma secretin concentration. Thesis, ISBN 82-990673-0-8, Oslo 1980 |
| 35 |
Hanssen LE. The effect of atropine on secretin release and aspirated bicarbonate secretion after duodenal acidification in man. Scand J Gastroenterol 1980; 15: 465-9. |
| 36 |
Hanssen LE, Hotz J, Hartmann W, Flaten O, Myren J, Goebell H. Secretin release by bile - an effect depending on bile salts, but not on pH. Regulatory Peptides 1980; 1 Suppl 1: S49. |
| 37 |
Hanssen LE, Hotz J, Hartmann W, Nehls W, Goebell H. Immunoreactive secretin release following taurocholate perfusions of the cat duodenum. Scand J Gastroenterol 1980; 15: 89-95. |
| 38 |
Hanssen LE, Kåresen R, Aune S. Effect of glucose on plasma immunoreactive secretin (IRS) in normal man, and after gastrectomy or pancreatectomy. Acta Endocrinol (Coph) 1980; 94 Suppl 237: 31. |
| 39 |
Hanssen LE, Kåresen R, Aune S. The effect of glucose on plasma
immunoreactive secretin in normal man and after gastrectomy or
pancreatectomy. Scand J Gastroenterol 1980; 15: 471-9. |
| 30 |
Hanssen LE, Myren J. Intraluminal gastrointestinal hormones and their radioimmunoassay: I. Secretin. Chapter 38. In: Glass GBJ, editor. Gastrointestinal Hormones. New York: Raven Press, 1980: 855-62. |
| 41 |
Melby K, Steinbak M, Løvland B, Hanssen LE. Kliniske erfaringer med to fenoksymetylpenicillin preparater (Fenoxypen granulat og Weifapenin granulat). Nor Farmac Tidsskr 1980; 88: 510-2. |
| 41 |
Osnes M, Hanssen LE. Does a feed back regulation of the exocrine pancreatic secretion and plasma levels of secretin induced by bile operate in man? Scand J Gastroenterol 1980; 15: 909. |
| 43 |
Osnes M, Hanssen LE. The influence of intraduodenal administration of pancreatic juice on the bile-induced pancreatic secretion and immunoreactive secretin release in man. Scand J Gastroenterol 1980; 15: 1041-7. |
| 44 |
Osnes M, Hanssen LE, Lehnert P, Flaten O, Larsen S, Londong W, Otte M. Exocrine pancreatic secretion and immunoreactive secretin release after repeated intraduodenal infusions of bile in man. Scand J Gastroenterol 1980; 15: 1033-9. |
| 45 |
Selbekk BH, Flaten O, Hanssen LE. The in vitro effect of neurotensin on human jejunal mast cells. Scand J Gastroenterol 1980; 15: 457-60. |
| 46 |
Selbekk BH, Flaten O, Hanssen LE, Stadaas J. The effect of 5 neuropeptides on human jejunal mast cells. Regulatory Peptides 1980; 1 Suppl 1: S103. |
| 47 |
Skare S, Hanssen LE, Hanssen KF, Aadland E. Somatostatin is present in human gastric juice; Pentagastrin stimulates somatostatin content in plasma and gastric juice in man. Regulatory Peptides 1980; 1 Suppl 1: S106. |
| 48 |
Tronier B, Hanssen LE, Kåresen R. Response to glucose of gut-glucagon-like immunoreactants (Gut-GLI) in pancreatectomized and gastrectomized humans. Diabetologia 1980; 19: 321. |
| 49 |
Valnes K, Flaten O, Hanssen LE, Foss OP, Gautvik KM. Plasma concentration of secretin and gastric secretion following intraduodenal calcium infusion in man. Scand J Gastroenterol 1980; 15: 881-5. |
| 50 |
Valnes K, Stave R, Brandtzaeg P, Hanssen LE, Myren J. Paired unlabelled antibody peroxidase-antiperoxidase (PAP) method and direct immunofluorescence (DIF) for concomitant demonstration of gastrin-(G) and somatostatin-(D) producing cells in human gastric antrum. Scand J Gastroenterol 1980; 15: 910. |
| 51 |
Flaten O, Hanssen LE, Osnes M, Myren J. Plasma concentrations of gastric inhibitory polypeptide after intraduodenal infusion of cattle bile and synthetic bile salts in man. Scand J Gastroenterol 1981; 16: 1073-5. |
| 52 |
Hanssen LE, Hotz J, Uesseler W, Maertens R, Myren J, Hartmann W, Goebell H. How bile stimulates secretin release in cats. Scand J Gastroenterol 1981; 16: 1113. |
| 53 |
Hartmann W, Hotz J, Hanssen LE, Kesseler W, Maertens R, Myren J, Goebell H. Stimulation der Pankreassekretion und Freisetzung von Sekretin durch intraduodenale Gabe von Galle und reinem Taurocholat in physiologischen Konzentration bei der Katze. Z Gastroenterol 1981; 19: 484-5. |
| 54 |
Hotz J, Hanssen LE, Uesseler W, Maertens R, Myren J, Hartmann W, Goebell H. Stimulation of feline pancreatic secretion and release of secretin by intraduodenal infusion of bile and pure taurocholate of physiological concentrations. Gastroenterol Clin Biol 1981; 5: 928-9. |
| 55 |
Kilander AF, Hanssen LE, Gillberg R. Response of plasma secretin and pancreatic secretion to duodenal acid infusion in coeliac disease. Scand J Gastroenterol 1981; 16: 1113. |
| 56 |
Knudtzon J, Hanssen LE. Thyrotropin-releasing hormone decreases the plasma levels of somatostatin in rabbits, with a secondary increase in the plasma levels of glucagon, insulin and glucose. Acta Endocrinolol (Coph) 1981; 97 Suppl 243: 83. |
| 57 |
Londong W, Londong V, Hanssen LE, Schwanner A. Gastric effects and side effects of synthetic secretin in man. Regulatory Peptides 1981; 2: 231-44. |
| 58 |
Niebel W, Hanssen LE, Goebell H, Singer MV. Wirkung von Atropin auf die durch intraduodenale Gabe von HCl stimulierte Bikarbonatsekretion des Pankreas und die Plasmaspiegel von Sekretin beim wachen Hund. Z Gastroenterol 1981; 19: 600. |
| 59 |
Niebel W, Hanssen LE, Singer MV. Effect of atropine on pancreatic bicarbonate secretion and plasma levels of secretin in response to intraduodenal (id) HCl. Gastroenterology 1981; 80: 1240. |
| 60 |
Niebel W, Hanssen LE, Singer MV. Effect of atropine on pancreatic bicarbonate secretion and plasma levels of secretin in response to intraduodenal (i.d.) HCl. Gastroenterol Clin Biol 1981; 5: 936-7. |
| 61 |
Osnes M. Studies on the exocrine pancreatic secretion following endoscopic cannulation of the main pancreatic duct in man. Thesis, Oslo 1981 |
| 62 |
Dolva LØ. Thyrotropin-releasing hormone; distribution and action in the gastrointetstinal tract of man. Thesis, ISBN 82-990-968-0-4, Oslo 1982 |
| 63 |
Flaten O. Studies on the glucose-induced release of gastric inhibitory polypeptide, pancreatic polypeptide, and neurotensin. Thesis, ISBN 82-990673-1-6, Oslo 1982 |
| 64 |
Flaten O, Hanssen LE. Concentration of neurotensin in human plasma after glucose, meals and lipids. Acta Physiol Scand 1982; 114: 311-3. |
| 65 |
Flaten O, Hanssen LE, Kåresen R, Aune S, Myren J. Glucose-induced release of neurotensin after gastric surgery. Digestion 1982; 24: 94-7. |
| 66 |
Flaten O, Hanssen LE, Kåresen R, Aune S, Myren J. Intestinal phase release of pancreatic polypeptide (PP) after oral glucose in patients with gastric resection. Horm Metabol Res 1982; 14: 613-4. |
| 67 |
Hanssen LE. Borborygmi - Tarmer som larmer. Nord Med 1982; 97: 67-9. |
| 68 |
Hanssen LE. Colon irritabile. Tidsskr Nor Lægeforen 1982; 102: 1139-40. |
| 69 |
Mogard M. Studies on gastrointestinal functions in relation to intestinal osmolality in the rat. Thesis, Stockholm, Sweden 1982 |
| 70 |
Mogard M, Nylander G, Flaten O, Hanssen LE. Gastric emptying and intestinal transit of hyperosmolar solutions in relation to indomethacin and certain gut polypeptides in the rat. In: Mogard M. Studies on gastrointestinal functions in relation to intestinal osmolality in the rat. Thesis, Stockholm 1982: 79-98. |
| 71 |
Dolva LØ, Hanssen KF, Flaten O, Hanssen LE, von Schenck H. The effect of thyrotropin-releasing hormone (TRH) on pancreatic hormone secretion in normal subjects. Acta Endocrinol (Coph) 1983; 102: 224-30. |
| 72 |
Haffner J, Linnestad P, Flaten O, Hanssen LE, Schrumpf E. PP, GIP, gastrin and somatostatin before and after renal transplantation. Scand J Gastroenterol 1983; 18 Suppl 86: 22. |
| 73 |
Hanssen LE, Hotz J. The regulation of pancreatic secretion by bile-induced secretin release and the inhibitory role of pure pancreatic juice. Dig Dis Sci 1983; 28: 936. |
| 74 |
Hanssen LE, Skare S, Hanssen KF. Histamine induced release of somatostatinlike immunoreactivity to gastric juice and peripheral blood in man. Hepato-Gastroenterology (Stuttg) 1983; 30: 73. |
| 75 |
Hanssen LE, Skare S, Hanssen KF. Somatostatin release to peripheral plasma and gastric juice in man - the effect of pentagastrin and cimetidine. In: Miyoshi A, editor. Gut peptides and ulcer. Tokyo: Biomedical Research Foundation, 1983: 293-6. |
| 76 |
Kilander AF, Hanssen LE, Gillberg RE. Secretin release in coeliac disease. Plasma secretin concentration and bicarbonate output to the duodenum after intraduodenal acid infusion in coeliac patients before and after treatment. Scand J Gastroenterol 1983; 18: 765-9. |
| 77 |
Knudtzon J, Hanssen LE. TRH increases plasma somatostatin-like
immunoreactivity in rabbits. Horm Metabol Res 1983; 15: 309-10. |
| 78 |
Linnestad P. Studies on the secretion of pancreatric polypeptide. Thesis, Oslo 1983 |
| 79 |
Linnestad P, Erichsen Aa, Fausa O, Flaten O, Hanssen LE, Schrumpf E. The release of human pancreatic polypeptide, gastrin, gastric inbitory polypeptide, and somatostatin in coeliac disease related to the histological appearance of jejunal mucosa before and 1 year after gluten withdrawal. Scand J Gastroenterol
1983; 18: 169-75. |
| 80 |
Michalsen H, Hanssen LE. The effect of duodenal acidification on secretin release in children with and without cystic fibrosis. In: Adam G, Valassi-Adam H, editors. Proceedings 12th annual meeting European working group cystic fibrosis. Athens 1983: 101-3. |
| 81 |
Myren J, Hanssen LE, Flaten O, Osnes M. Gastrointestinal hormones and bicarbonate secretion into the duodenum, with special reference to the effect of secretin and gastric inhibitory polypeptide (GIP). In: Miyoshi A, editor. Gut peptides and ulcer. Tokyo: Biomedical Research Foundation, 1983: 106-9. |
| 82 |
Niebel W, Singer MV, Hanssen LE, Goebell H. Effect of atropine on pancreatic bicarbonate output and plasma concentrations of immunoreactive secretin in response to intraduodenal stimulants. Scand J Gastroenterol 1983; 18: 803-8. |
| 83 |
Niebel W, Singer MV, Hanssen LE, Goebell H. Effect of atropine on pancreatic bicarbonate output and plasma concentrations of immunoreactive secretin (IRS) in response to intraduodenal (i.d.) stimulants. Digestion 1983; 28: 51-2. |
| 84 |
Niebel W, Singer MV, Hanssen LE, Goebell H. Effect of atropine on pancreatic bicarbonate output and plasma concentrations of immunoreactive secretin (IRS) in response to intraduodenal (ID) stimulants. Gastroenterology 1983; 84: 1260. |
| 85 |
Niebel W, Singer MV, Hanssen LE, Goebell H. Wirkung von Atropin auf die durch intraduodenale (ID) Gabe von HCl, Natriumoleat und Tryptophan stimulierte Bikarbonatsekretion des Pankreas und die Plasmaspiegel von Sekretin beim wachen Hund. Z Gastroenterol 1983; 21: 389. |
| 86 |
Salera M, Giacomoni P, Hanssen LE, Pironi L, Capelli M, Miglioli M, Barbara L. Effect of bombesin on fasting and glucose-stimulated gastric inhibitory polypeptide (GIP) release in man. Ital J Gastroenterol 1983; 15: 241-5. |
| 87 |
Schrumpf E, Arnesjø B, Bergan A, Burhol P, Fausa O, Giercksky K-E, Haffner J, Halvorsen L, Hanssen LE, Osnes M, Petersen H, Ritland S, Roland M, Rosseland A, Skarstein A, editors. Abstract of papers presented at the sixteenth Scandinavian conference on gastroenterology and the seventh Scandinavian meeting on gastrointestinal endoscopy. Scand J Gastroenterol 1983; 18 Suppl 86. |
| 88 |
Valnes K, Brandtzaeg P, Hanssen LE, Stave R, Larsen S, Londong W. Quantitation of immunoglobulin- and peptide hormone-producing cells in gastrointestinal mucosa. Comparison of direct immunofluorescence and the
unlabelled antibody peroxidase-antiperoxidase method. Histochem J 1983; 15: 1011-20. |
| 89 |
Hanssen LE, Londong W, Heilmaier L, Londong V. Gastric and renal effects of synthetic somatostatin and secretin in man. Dig Dis Sci 1984; 29 Suppl: 35S. |
| 90 |
Hanssen LE, Michalsen H. Impaired secretin release in children with chronic non-coeliac diarrhoea, and enhanced release in CF (cystic fibrosis). Dig Dis Sci 1984; 29 Suppl: 35S. |
| 91 |
Hanssen LE, Myren J, Berstad A, Mosvold J, Osnes M, Stave R, Valnes K. The effect of a new antisecretory drug (RP 40749) on plasma concentrations of somatostatin and gastrin in a double-blind cross-over study. Dig Dis Sci 1984; 29 Suppl: 35S. |
| 92 |
Londong W, Hanssen LE, Heilmaier L, Londong V, Richter W, Weber PC. Do endogenous prostaglandins mediate gastric, but not renal effects of secretin and somatostatin? Dig Dis Sci 1984; 29 Suppl: 49S. |
| 93 |
Mosvold J, Stave R, Hanssen LE, Osnes M, Valnes K, Berstad A, Myren J. Serum concentration of RP 40 749 and gastric acidity. Scand J Gastroenterol 1984; 19 Suppl 98: 55. |
| 94 |
Myren J, Berstad A, Stave R, Mosvold J, Hanssen LE, Osnes M, Valnes K. Repeated 24 hours studies of the gastric peptic activity and acidity following a new antisecretory compound in patients with previous duodenal ulcer. Scand J Gastroenterol 1984; 19 Suppl 98: 3. |
| 95 |
Selbekk BH. Mast cell studies in human jejunal mucosa. Thesis, ISBN 82-990673-3-2, Oslo 1984 |
| 96 |
Hanssen LE. Luftplager - Hva gjør vi galt? Therapia Medica 1985; 4: 23-5. |
| 97 |
Hanssen LE, Holm H, Krogdahl Å. The effect of soy bean proteinase inhibitors on secretin levels and pancreatic secretion in man. Dig Dis Sci 1985; 30: 974. |
| 98 |
Heilmaier L. Pharmakodynamische Untersuchungen zur Wirkung von Sekretin und Somatostatin an Magen und Niere beim Menschen, Thesis, München, Germany 1985 |
| 99 |
Kilander AF. Gluten-sensitive enteropathy. Studies on plasma enteroglucagon and secretin and serum antibodies to gliadin. Thesis, ISBN 91-72222-850-4, Gothenburg, Sweden 1985 |
| 100 |
Londong W, Londong V, Hanssen LE, Heilmaier L, Richter W, Weber PC. Endogenous prostaglandins mediate gastric, but not renal effects of secretin and somatostatin in man. Hepato-Gastroenterol (Stuttg) 1985; 32: 48. |
| 101 |
Lunde OC, Kvernebo K, Hanssen LE. Effects of proximal gastric vagotomy, pentagastrin and somatostatin on human gastric circulation evaluated by laser doppler flowmetry. Scand J Gastroenterol 1985; 20 Suppl 113: 29. |
| 102 |
Mellem H, Stave R, Myren J, Osnes M, Hanssen LE, Mosvold J, Hebnes K. Do non-steroid anti-inflammatory drugs (NSAIDs) mask ulcer symptoms? Br Med J 1985; 290: 1628. |
| 103 |
Mellem H, Stave R, Myren J, Osnes M, Hanssen LE, Mosvold J, Hebnes K. Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol 1985; 20: 1246-8. |
| 104 |
Mellem H, Stave R, Myren J, Osnes M, Hanssen LE, Mosvold J, Hebnes K. A masking effect by non steroid antiinflammatory drugs (NSAID) on symptoms in patients with ulcer and haematemesis and or melena? Scand J Gastroenterol 1985; 20 Suppl 113: 15. |
| 105 |
Myren J, Stave R, Mosvold J, Hanssen LE, Linnestad P, Osnes M, Larsen S, Berstad A, Valnes K, Lorentzen-Lund S, Rosetzsky A, Frydman A. The antisecretory effects of RP 40749 in patients with previous duodenal ulcer. Scand J Gastroenterol 1985; 20: 1025-34. |
| 106 |
Baksaas I, Hanssen LE, Farbrot TO. Ulcussykdommer i Norge -en
helseøkonomisk vurdering. In: Baksaas I, Vatn MH editors. Ulcusstrategi - bakgrunn for, utredning, behandling og oppfølging ved ulcussykdommer. Oslo: Institutt for Farmakoterapi, 1986: 100-15. |
| 107 |
Baksaas I, Vatn M, Guldvog I, Hanssen LE, Linnestad P, Lunde PKM. Survey on peptic ulcer and associated disorders in Norway 1985. Acta Pharmacol Toxicol 1986; 59 Suppl 5: 208. |
| 108 |
Demol P, Singer MV, Hotz J, Hoffmannn U, Hanssen LE, Eysselein VE, Goebell H. Action of intragastric ethanol on pancreatic exocrine secretion in relation to the inter-digestive gastrointestinal motilty in humans. Arch Internat Physiol Biochim 1986; 94: 251-9. |
| 109 |
Hanssen LE, Holm H, Krogdahl Å, Florholmen J. Gut peptide response to soybean proteinase inhibitors in man. Canad J Physiol Pharmacol 1986 Suppl 1: 91. |
| 110 |
Hanssen LE, Holm H, Krogdahl Å, Florholmen J. Pancreatic feed-back response to soybean proteinase inhibitors in man. Dig Dis Sci 1986; 31: 1133. |
| 111 |
Hanssen LE, Hotz J, Layer P, Goebell H. Bile-stimulated secretin release in cats. Scand J Gastroenterol 1986; 21: 886-90. |
| 112 |
Hotz J, Hanssen LE, Layer P, Goebell H. Bile-stimulated secretin release in cats. Dig Dis Sci 1986; 31 Suppl: 157S. |
| 113 |
Jervell J, Hanssen LE, Reinlie S, Stokke KT, Stray-Pedersen S, Halse J, Brownell J. A new dopamine agonist in the treatment of hyperprolactinemia. J Med Ass Thailand 1986; 69 Suppl 3: 75. |
| 114 |
Mogard MH, Nylander G, Flaten O, Hanssen LE. Gastric emptying and intestinal transit of hyperosmolar solutions in relation to indomethacin and certain gut polypeptides in the rat. Scand J Gastroenterol 1986; 21: 348-52. |
| 115 |
Myren J, Linnestad P, Stave R, Hanssen LE, Dolva Ø, Serck-Hanssen A, Strømme JH, Arnesen K. Effect of somatostatin and thyroid-releasing hormone (TRH) on liver and pancreatic injury in mice after single injections of CCl4. Digestion 1986; 35: 42. |
| 116 |
Myren J, Linnestad P, Stave R, Hanssen LE, Dolva Ø, Serck-Hanssen A, Strømme JH, Arnesen K. The effect of somatostatin and thyroid-releasing hormone on the liver injury in mice after single injections of carbon tetrachloride. Canad J Physiol Pharmacol 1986; Suppl 1: 123. |
| 117 |
Myren J, Linnestad P, Stave R, Hanssen LE, Dolva Ø, Serck-Hanssen A, Strømme JH, Arnesen K. The effect of the somatostatin analogue (Sandoz) on the liver injury following single injections of carbon tetrachloride in mice. Canad J Physiol Pharmacol 1986; Suppl 1: 73. |
| 118 |
Stokke KT, Hanssen LE, Reinlie S, Stray-Pedersen S, Halse J, Jervell J. A new dopamine agonist in the treatment of hyperprolactinaemia. Neuroendocrinology 1986; Suppl 1: 62. |
| 119 |
Baksaas I, Hanssen LE, Farbrot TO. Ulcussykdommer i Norge -en
helseøkonomisk vurdering. Nord Med 1987; 102: 166-9. |
| 120 |
Dolva LØ, Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J. Recombinant human alpha2-interferon in the treatment of malignant metastatic carcinoid tumors. Proc 4th European Conference on Clinical Oncology and Cancer Nursing 1987; 4: 45. |
| 121 |
Haffner J, Linnestad P, Schrumpf E, Hanssen LE, Flaten O, Øyasæther S. The immediate effect of human renal transplantation on basal and meal-stimulated levels of gastro-intestinal hormones. Scand J Gastroenterol 1987; 22: 42-6. |
| 122 |
Hanssen LE, Holm H, Krogdahl Å, Florholmen J. Lack of feed-back effect of raw soy bean proteinase inhibitors on CCK release in man. Scand J Gastroenterol 1987; 22 Suppl 135: 43. |
| 123 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LØ. Recombinant human alpha2-interferon in the treatment of malignant metastatic midgut carcinoid tumours. J Interferon Res 1987; 7: 735. |
| 124 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LØ. The treatment of malignant metastatic carcinoid tumours with recombinant human alpha2-interferon. Scand J Gastroenterol 1987; 22 Suppl 135: 25. |
| 125 |
Linnestad P, Hanssen LE, Schrumpf E, Slettebø M, Øyasæter S. Diminution of postprandial release of pancreatic polypeptide in myotonic dystrophy. Acta Neurol Belg 1987; 87: 66-9. |
| 126 |
Lunde OC, Kvernebo K, Hanssen LE, Larsen S. Effect of somatostatin on human gastric blood flow evaluated by endoscopic laser doppler flowmetry. Scand J Gastroenterol 1987; 22: 842-6. |
| 127 |
Bang S, Myren J, Linnestad P, Stave R, Hanssen LE, Dolva Ø, Serck-Hanssen A, Arnesen K, Beraki K, Vågene S. Liver and pancreatic injuries following repeated injections of carbon tetrachloride for 6 months. Digestion 1988; 40: 68-9. |
| 128 |
Beglinger C, Koehler E, Born W, Fischer JA, Keller U, Hanssen LE, Gyr K. Effect of calcitonin and calcitonin gene-related peptide on pancreatic functions in man. Gut 1988; 29: 243-8. |
| 129 |
Dolva LØ, Hanssen LE. Endokrine gastrointestinale tumorer -Udredning og behandling. Sandoz Tidsskrift (Coph) 1988; 4: 7-12. |
| 130 |
Dolva LØ, Hanssen LE. Endokrine gastrointestinale tumores. Utredning og behandling. Sandoz Informasjon (Oslo) 1988; 1: 16-20. |
| 131 |
Hanssen LE, Brownell J, Halse J, Jervell J, Stokke KT, Reinlie S, Stray-Pedersen S. CQP 201-403, a new dopamine agonist in the treatment of hyperprolactinemia. Acta Endocrinol (Coph) 1988; 117: 552-6. |
| 132 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Kolmannskog F, Dolva LØ. Effective treatment of malignant metastatic mid-gut carcinoids with human alpha2 recombinant interferon. Biomed Res 1988; 9 Suppl 1: 97. |
| 133 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Kolmannskog F, Tausjø J, Dolva LØ. Effective treatment of malignant metastatic mid-gut carcinoids with human alpha2 recombinant interferon. Gastroenterol Internat 1988; 1 Suppl 1: 802. |
| 134 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Kolmannskog F, Tausjø J, Dolva LØ. Re-activation of carcinoid syndrome after discontinuation of therapy with recombinant interferon alpha 2b, Intron A (Schering). Proc Chinese Acad Med Sci Peking Union Med Coll 1988; 3 Suppl 2: 115. |
| 135 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LØ. Re-activation of carcinoid syndrome after discontinuation of therapy with recombinant interferon alfa 2b, Intron A. Scand J Gastroenterol 1988; 23 Suppl 145: 36. |
| 136 |
Holm H, Hanssen LE, Krogdahl Å, Florholmen J. High and low inhibitor soybean meals affect human duodenal proteinase activity differently: in vivo comparison with bovine serum albumin. J Nutr 1988; 118: 515-20. |
| 137 |
Holm H, Krogdahl Å, Hanssen LE. High and low inhibitor soybean meals affect human duodenal proteinase activity differently: in vitro comparison of proteinase inhibition. J Nutr 1988; 118: 521-5. |
| 138 |
Lunde OC. Endoscopic laser doppler flowmetry in evaluation of human gastric blood flow. Thesis, ISBN 82-991793-0-0, Oslo 1988 |
| 139 |
Myren J, Bang S, Linnestad P, Stave R, Hanssen LE, Dolva LØ, Serck-Hanssen A, Arnesen K, Beraki K, Vågene S. Liver and pancreatic injuries following repeated injections of carbon tetrachloride for 6 months. Proc Chinese Acad
Med Sci Peking Union Med Coll 1988; 3 Suppl 2: 93. |
| 140 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LØ. Recombinant α-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report. Acta Oncol 1989; 28: 439-43. |
| 141 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Tausjø J, Dolva LØ. Treatment of metastatic midgut carcinoid tumours with recombinant human α2b interferon with or without prior hepatic artery embolization. Scand J Gastroenterol 1989; 24: 787-95. |
| 142 |
Myren J, Bang S, Linnestad P, Stave R, Hanssen LE, Dolva LØ, Serck-Hanssen A, Arnesen K, Strømme J, Beraki K, Vågene S. Liver cell necrosis and regeneration following injections of carbon tetrachloride. Effects of the thyrotropin-releasing hormone and somatostatin. Acta Pathol Microbiol Scand 1989; 97: 334-42. |
| 143 |
Richter W. Endogenes Prostanoidsystem - Kein Mediator der Pharmakologischen Somatostatin- und Sekretinwirkung an Magen und Niere des Menschen. Thesis, München, Germany 1989 |
| 144 |
Valnes KN. Two-colour immunohistochemistry for studies of immunological factors in human gastric mucosa. Thesis, ISBN 82-90252-250, Oslo 1989 |
| 145 |
Hanssen LE, Schrumpf E, Kolbenstvedt AN, Kolmannskog F, Bergan A. Increased 5-HIAA output in carcinoids after stopping interferon treatment. Scand J Gastroenterol 1990; 25 Suppl 176: 70. |
| 146 |
Myren J, Bang S, Linnestad P, Strømme JH, Serck-Hanssen A, Hanssen LE. The somatostatin analogue SMS-201 995 and liver cell injury after single injections of carbon tetrachloride. Digestion 1990; 46 Suppl 1: 74. |
| 147 |
Søreide O, Bergan A, Bakka A, Berstad T, Flatmark A, Hanssen LE, Schrumpf E. Intervention directed at the liver in patients with mid-gut tumours - what can be achieved? HPB Surgery 1990; 2 Suppl: 254. |
| 148 |
Theodorsson E, Larsen S, Riis P, Hanssen LE. Statistical guidelines for contributors to Scandinavian Journal of Gastroenterology. Scand J Gastroenterol 1990; 25: 545-7. |
| 149 |
Aspestrand F, Schrumpf E, Jacoben MB, Hanssen LE, Endresen K. Increased lymphatic flow from the liver in different intra- and extrahepatic diseases demonstrated by CT. J Comput Assist Tomogr 1991; 15: 550-4. |
| 150 |
Forfang K, Fauchald P, Flatmark A, Hanssen LE, Thorsby E. Rikshospitalets medisinske funksjoner. Oslo 1991 |
| 151 |
Funk J, Langeland T, Schrumpf E, Hanssen LE. Psoriasis induced by interferon-
α. Br J Dermatol 1991; 125: 463-5. |
| 152 |
Hanssen LE, Schrumpf E, Jacobsen MB, Kolbenstvedt AN, Kolmannskog F,
Bergan A, Dolva LØ. Extended experience with recombinant α-2b interferon with
or without hepatic artery embolization in the treatment of midgut carcinoid
tumours. Acta Oncol 1991; 30: 523-8. |
| 153 |
Hanssen LE, Vatn MH, Norheim Andersen S, Grimelius L. Do acromegalics
have more polyps in the colon? Scand J Gastroenterol 1991; 26 Suppl 183: 76. |
| 154 |
Holm H, Hanssen LE, Reseland J, Thoresen L, Florholmen J, Jenssen T,
Krogdahl Å, Brosstad F. In vivo effects of raw soy beans and proteinase
inhibitors. Scand J Gastroenterol 1991; 26 Suppl 183: 87. |
| 155 |
Holm H, Jørgensen A, Hanssen LE. Raw soy and purified proteinase inhibitors induce the appearance of inhibitor-resistant trypsin and chymotrypsin activities in Wistar rat duodenal juice. J Nutr 1991; 121: 532-8. |
| 156 |
Jacobsen MB, Ahlman H, Hanssen LE, Bratlie J. The influence of SandostatinR on the serotonin content in the medium from primary carcinoid cell culture. Scand J Gastroenterol 1991; 26 Suppl 183: 71. |
| 157 |
Kolmannskog F, Kolbenstvedt AN, Schrumpf E, Hanssen LE. Side effects and complications following hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol 1991; 26: 557-62. |
| 158 |
Thorsen LI, Holm H, Reseland JE, Bjørnsen S, Hanssen LE, Brosstad F.
Characterization of a human trypsin resistant to Kunitz soybean trypsin inhibitor. Studies of duodenal juices after tube instillation of raw soybean extract. Scand J Gastroenterol 1991; 26: 589-98. |
| 159 |
Hanssen LE, Jacobsen MB, Bergan A, Kolbenstvedt AN, Kolmannskog F,
Schrumpf E. Surgery, embolization and interferon in midgut carcinoids. Scand J Gastroenterol 1992; 27 Suppl 190: 68. |
| 160 |
Holm H, Reseland JE, Thorsen LI, Flatmark A, Hanssen LE. Raw soybeans
stimulate human pancreatic proteinase secretion. J Nutr 1992; 122: 1407-16. |
| 161 |
Jacobsen MB, Bratlie J, Hellesnes J, Hanssen LE. Changes in serotonin
concentrations in the medium of primary carcinoid cell culture following radiation. Scand J Gastroenterol 1992; 27 Suppl 190: 30. |
| 162 |
Jacobsen MB, Hanssen LE, Bratlie J. The effect of somatostatin analogue SMS 201-995 on serotonin levels in the medium of primary carcinoid cell cultures. Scand J Gastroenterol 1992; 27: 1077-83. |
| 163 |
Reseland JE, Holm H, Hanssen LE. The effect of purified serine proteinase
inhibitors on the stimulation and regulation of pancreas proteinases. Scand J Gastroenterol 1992; 27 Suppl 190: 70. |
| 164 |
Søreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V, Bergan A,
Flatmark A. Surgical treatment as a principle in patients with advanced carcinoid tumors. Surgery 1992; 111: 48-54. |
| 165 |
Jacobsen MB, Bratlie J, Reitan JB, Hellesnes J, Hanssen LE. Influence of
interferon and radiation on serotonin content in primary carcinoid cell cultures. Acta Oncol 1993; 32: 239-43. |
| 166 |
Solheim BG, Leivestad T, Hanssen LE. Endringer i blodforbruk - betydningen av ressursmessige og økonomiske forhold. Tidsskr Nor Lægeforen 1993; 113: 61-5. |
| 167 |
Syversen U, Jacobsen MB, Hanssen LE, O'Connor DT, Waldum HL.
Chromogranin A and pancreastatin-like immunoreactivity in human carcinoid disease. Eur J Gastroenterol Hepatol 1993; 5: 1043-50. |
| 168 |
Bentdal ØH, Frøland SS, Hanssen LE, Mørkrid L. Possible modulating effect of growth hormone and TSH on immune responses in the malnutrition og anorexia nervosa. Endocrine 1994; 2: 1067-70. |
| 169 |
Hanssen LE. Scandinavian Journal of Gastroenterology - An international
Journal (Editorial). Scand J Gastroenterol 1994; 29: 1. |
| 170 |
Hanssen LE. Signal frå tilsynsføraren (Correspondance). Tidsskr Nor Lægeforen 1994; 114: 3490. |
| 171 |
Holm H, Reseland JE, Jacobsen MB, Hanssen LE. The rat model is invalid in enzyme secretion studies of the human pancreas. Gut 1994; 35 Suppl 4: A226. |
| 172 |
Holmboe J, Hanssen LE. Brystproteser av silikon (Commentary). Tidsskr Nor Lægeforen 1994; 114: 3490. |
| 173 |
Jacobsen MB, Bratlie J, Brunborg G, Hanssen LE. Interferon-α2b alone and
combined with octreotide in primary carcinoid cell cultures. Oncol Rep 1994; 1: 1165-70. |
| 174 |
Jacobsen MB, Bratlie J, Hanssen LE. The effect of combined octreotide and
interferon on the serotonin levels in the medium of primary carcinoid tumours. Dig Dis Sci 1994; 39: 1744. |
| 175 |
Jacobsen M, Kolmanskog F, Bergan A, Vatn M, Schrumpf E, Hanssen LE.
Interferon and embolization in mid-gut carcinoid. Gut 1994; 35 Suppl 4: A64-5. |
| 176 |
Jacobsen MB, Nitter-Hauge S, Hanssen LE. Carcinoid heart disease. Gut 1994; 35 Suppl 4: A65. |
| 177 |
Jacobsen MB, Nitter-Hauge S, Hanssen LE. Cardiac manifestations in mid-gut carcinoid disease. Dig Dis Sci 1994; 39: 1744. |
| 178 |
Jacobsen MB, Vatn MH, Schrumpf E, Kolmannskog F, Bergan A, Hanssen LE. Mid-gut carcinoid tumours. The effects of interferon treatment, with or without prior hepatic artery embolization on clinical response and survival. Dig Dis Sci 1994; 39: 1744. |
| 179 |
Larsen F. Studies on CpG islands and genes in the human genome. Thesis, ISBN 82-7722-023-5, Oslo 1994 |
| 180 |
Reseland JE, Holm H, Jacobsen MB, Hanssen LE. Selective regulation of
individual exocrine pancreatic proteinases in man. Gut 1994; 35 Suppl 4: A231. |
| 181 |
Syversen U. Chromogranin A - physiological and clinical role. Thesis, ISBN 82-519-1427-2, Trondheim 1994 |
| 182 |
Hanssen LE: Scandinavian Journal of Gastroenterology - A progress report
(Editorial). Scand J Gastroenterol 1995; 30: 1137 |
| 183 |
Holm H. Soybean proteinase inhibitors and regulation of human pancreatic
secretion. Thesis, ISBN 82-91061-60-2, Oslo 1995 |
| 184 |
Jacobsen MB. Therapeutical options in carcinoid mid-gut disease. Evaluations by clinical and cell culture studies. The Norwegian carcinoid study. Thesis, ISBN 82-7722-027-8, Oslo 1995 |
| 185 |
Jacobsen MB, Hanssen LE. Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial. J Int Med 1995; 237: 269-75. |
| 186 |
Jacobsen MB, Nitter-Hauge S, Bryde P, Hanssen LE. Cardiac manifestations of mid-gut carcinoid disease. Eur Heart J 1995; 16: 263-8. |
| 187 |
Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A. Interferon-α2b, with or without prior hepatic artery embolization: Clinical
response and survival in mid-gut carcinoid patients. Scand J Gastroenterol 1995; 30: 789-96. |
| 188 |
Reseland JE. Inhibitor-induced stimulation of human pancreatic exocrine
secretion. Thesis, ISBN 82-992777-5-2, Oslo 1995 |
| 189 |
Reseland JE, Holm H, Jenssen TG, Hanssen LE. Inhibitor-stimulated nonparallel pancreatic secretion in man: Hormonal and neural regulation? Scand J Gastroenterol 1995; 30: 72-80. |
| 190 |
Bentdal ØH. Immune responses in protein-energy-malnutrition. Thesis, ISBN 82-7722-050-2, Oslo 1996 |
| 191 |
Hanssen LE. Helsetilsynets klagesaksbehandling. YLF Forum 1996; 11: 22-23. |
| 192 |
Hanssen LE. Statens helsetilsyns rolle angående reaksjoner mot leger. YLF Forum 1996; 11: 20-21. |
| 193 |
Reseland JE, Holm H, Jacobsen MB, Jenssen TG, Hanssen LE. Proetinase
inhibitors induce selective stimulation of human trypsin and chymotrypsin
secretion. J Nutr 1996; 126: 634-42. |
| 194 |
Reseland JE, Larsen F, Solheim J, Eriksen JA, Hanssen LE, Prydz H. A novel human chymotrypsin-like digestive enzyme. J Biol Chem 1997; 272: 8099-8104. |
| 195 |
Hanssen LE. Helsetilsynet og legers rettssikkerhet. Tidsskr Nor Lægerforen 1999; 119: 1649-50. |
| 196 |
Hanssen LE. HIV/AIDS-forebyggende arbeid i Norge. Kronikk Aftenposten
(morgenutgaven) 1.12.2000 |
| 197 |
Hanssen LE. Frå kunnskap til handling. Forum for organisasjonsutvikling i
sykehus 2000; (3): 3. |
| 198 |
Hanssen LE. Fattigdom tung å bære. Kronikk Dagbladet 18.5.2001 |
| 199 |
Hanssen LE. L.E. Hanssen svarer [om fullføring av arbeidet med ny dødsattest] Tidsskr Nor Lægeforen 2001; 121: 2996. |
| 200 |
Hanssen LE. Med en helsesektor i smeltedigelen. Tidsskr Helse Med Teknikk 2001; (3): 5-6. |
| 201 |
Hanssen LE. , Braut GS. Tilsyn er meir enn dokumentlesing. Leserbrev Aftenposten (morgenutgaven) 8.6.2002 |
| 202 |
Hanssen LE, Pedersen BP. Feilmedisinering – en fare for liv og helse. Kronikk. Aftenposten (morgenutgaven) 21.11.2002 |
| 203 |
Hanssen LE, Schou P. L.E. Hanssen & P. Schou svarer [om ambulansetjenesten i Finnmark] Tidsskr Nor Lægeforen 2002; 122: 1821-2 |
| 204 |
NOU 2005:1 God forskning - bedre helse. ISBN 82-583-0818-1, Oslo 2005 |